Fibrinogen human

Generic Name
Fibrinogen human
Brand Names
Artiss, Evarrest, Evicel, Fibryga, Riastap, Tachosil, Tisseel, Vistaseal
Drug Type
Biotech
Chemical Formula
-
CAS Number
9001-32-5
Unique Ingredient Identifier
N94833051K
Background

Fibrinogen concentrate (human) is a hematological agent. It works by replacing a certain protein in the blood that helps with blood clotting. Fibrinogen (factor I) is a soluble plasma glycoprotein with a molecular weight of about 340 kDa. It is a physiological substrate for three enzymes: plasmin, factor XIIIa and thrombin. It is indicated for the treatment ...

Indication

Human fibrinogen is used for the treatment of acute bleeding episodes in patients with congenital fibrinogen deficiency, including afibrinogenemia and hypofibrinogenemia.
...

Associated Conditions
Bleeding, Dura Mater Nick Cut or Tear, Surgical Bleeding, Acute bleeding episodes
Associated Therapies
Tissue Adhesions, Maintenance of surgical hemostasis therapy

Effectiveness of Different Fibrinogen Preparations in Restoring Clot Firmness

First Posted Date
2023-03-22
Last Posted Date
2024-02-28
Lead Sponsor
IRCCS Policlinico S. Donato
Target Recruit Count
40
Registration Number
NCT05780125
Locations
🇮🇹

IRCCS Policlinico San Donato, San Donato Milanese, MI, Italy

Effect of Prophylactic Fibrinogen Concentrate In Scoliosis Surgery

First Posted Date
2022-05-26
Last Posted Date
2023-03-28
Lead Sponsor
Brno University Hospital
Target Recruit Count
32
Registration Number
NCT05391412
Locations
🇨🇿

University Hospital Brno, Brno, Czechia

Administration of Fibrinogen Concentrate for Refractory Bleeding

First Posted Date
2021-10-25
Last Posted Date
2024-10-30
Lead Sponsor
Centre Hospitalier Universitaire de Saint Etienne
Target Recruit Count
10
Registration Number
NCT05091684
Locations
🇫🇷

CHU de Saint-Etienne, Saint-Étienne, France

Comparison of Fibrinogen Concentrate and Cryoprecipitate in Pediatric Cardiac Surgery Patients

Phase 4
Completed
Conditions
Interventions
First Posted Date
2020-05-06
Last Posted Date
2023-10-23
Lead Sponsor
University of Virginia
Target Recruit Count
30
Registration Number
NCT04376762
Locations
🇺🇸

University of Virginia Health System, Charlottesville, Virginia, United States

Use of Fibryga, a Fibrinogen Concentrate in Real World: Retrospective Collection of Clinical Data

Completed
Conditions
Interventions
First Posted Date
2019-09-27
Last Posted Date
2021-05-13
Lead Sponsor
Octapharma
Target Recruit Count
200
Registration Number
NCT04106895
Locations
🇫🇷

Le Plessis Robinsin Study Site, Le Plessis-Robinson, France

🇫🇷

Nantes Study Site, Nantes, France

🇫🇷

Marseille Study Site, Marseille, France

and more 2 locations

Safety and Efficacy of Fibryga in Congenital Fibrinogen Deficiency

First Posted Date
2019-01-04
Last Posted Date
2024-12-13
Lead Sponsor
Octapharma
Target Recruit Count
25
Registration Number
NCT03793426
Locations
🇩🇪

Gerinnungszentrum rhein-ruhr, Duisburg, Germany

🇨🇿

Fakultní nemocnice Ostrava, Ostrava, Czechia

🇩🇪

Gerinnungszentrum Hochtaunus, Hamburg, Germany

and more 1 locations

The Effects of Fibrinogen Concentrate Infusion on Blood Loss and Allogeneic Blood Conservation in Scoliosis Surgery

First Posted Date
2017-06-12
Last Posted Date
2020-03-02
Lead Sponsor
Peking Union Medical College Hospital
Target Recruit Count
102
Registration Number
NCT03183479
Locations
🇨🇳

Peking Union Medical College Hospital, Beijing, Beijing, China

Human Fibrinogen Concentrate in Pediatric Cardiac Surgery

First Posted Date
2016-07-04
Last Posted Date
2021-09-16
Lead Sponsor
Nicklaus Children's Hospital f/k/a Miami Children's Hospital
Target Recruit Count
30
Registration Number
NCT02822599
Locations
🇺🇸

Nickalus Children's Hospital f/k/a Miami Children's Hospital, Miami, Florida, United States

🇺🇸

Nicklaus Children's Hospital, Miami, Florida, United States

© Copyright 2024. All Rights Reserved by MedPath